Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner

Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 133; no. 3; pp. 872 - 879.e7
Main Authors Wambre, Erik, DeLong, Jonathan H., James, Eddie A., Torres-Chinn, Nadia, Pfützner, Wolfgang, Möbs, Christian, Durham, Stephen R., Till, Stephen J., Robinson, David, Kwok, William W.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.03.2014
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0091-6749
1097-6825
1097-6825
DOI10.1016/j.jaci.2013.10.054

Cover

Loading…
Abstract Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach. CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
AbstractList Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach. CD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach. CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
Background: Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.
Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.BACKGROUNDUnderstanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies.We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.OBJECTIVEWe sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4(+) T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy.Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach.METHODSTimothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using an ex vivo peptide-MHC class II tetramer approach.CD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.RESULTSCD4(+) T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells.Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.CONCLUSIONSPreferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. Objective We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+ T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Methods Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine–treated subjects was determined by using an ex vivo peptide–MHC class II tetramer approach. Results CD4+ T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH 2 or TH 1/TR 1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH 2 cells and without a significant change in the frequency of TH 1/TR 1 cells. Conclusions Preferential allergen-specific TH 2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of new allergy vaccine strategies. Objective We sought to characterize allergen-specific T-cell responses linked with allergy or peripheral tolerance and to determine how CD4+T-cell responses to individual allergen-derived epitopes change over allergen-specific immunotherapy. Methods Timothy grass pollen (TGP) allergy was used as a model for studying grass pollen allergies. The breadth, magnitude, epitope hierarchy, and phenotype of the DR04:01-restricted TGP-specific T-cell responses in 10 subjects with grass pollen allergy, 5 nonatopic subjects, and 6 allergy vaccine-treated subjects was determined by using anex vivopeptide-MHC class II tetramer approach. Results CD4+T cells in allergic subjects are directed to a broad range of TGP epitopes characterized by defined immunodominance hierarchy patterns and with distinct functional profiles that depend on the epitope recognized. Epitopes that are restricted specifically to either TH2 or TH1/TR1 responses were identified. Allergen-specific immunotherapy was associated with preferential deletion of allergen-specific TH2 cells and without a significant change in the frequency of TH1/TR1 cells. Conclusions Preferential allergen-specific TH2 cell deletion after repeated high-dose antigen stimulation can be another independent mechanism to restore tolerance to allergen during immunotherapy.
Author DeLong, Jonathan H.
Kwok, William W.
Wambre, Erik
Durham, Stephen R.
Till, Stephen J.
Torres-Chinn, Nadia
Möbs, Christian
Robinson, David
Pfützner, Wolfgang
James, Eddie A.
AuthorAffiliation 3 Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom
1 Benaroya Research Institute at Virginia Mason, Seattle, WA, USA
4 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom
6 Department of Medicine, University of Washington, Seattle, WA
5 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom
2 Department of Dermatology and Allergology, University Medical Center, Marburg, Germany
AuthorAffiliation_xml – name: 4 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom
– name: 6 Department of Medicine, University of Washington, Seattle, WA
– name: 1 Benaroya Research Institute at Virginia Mason, Seattle, WA, USA
– name: 2 Department of Dermatology and Allergology, University Medical Center, Marburg, Germany
– name: 3 Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom
– name: 5 Allergy, Asthma and Lung Biology, King’s College London, United Kingdom
Author_xml – sequence: 1
  givenname: Erik
  surname: Wambre
  fullname: Wambre, Erik
  organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash
– sequence: 2
  givenname: Jonathan H.
  surname: DeLong
  fullname: DeLong, Jonathan H.
  organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash
– sequence: 3
  givenname: Eddie A.
  surname: James
  fullname: James, Eddie A.
  organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash
– sequence: 4
  givenname: Nadia
  surname: Torres-Chinn
  fullname: Torres-Chinn, Nadia
  organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash
– sequence: 5
  givenname: Wolfgang
  surname: Pfützner
  fullname: Pfützner, Wolfgang
  organization: Department of Dermatology and Allergology, University Medical Center, Marburg, Germany
– sequence: 6
  givenname: Christian
  surname: Möbs
  fullname: Möbs, Christian
  organization: Department of Dermatology and Allergology, University Medical Center, Marburg, Germany
– sequence: 7
  givenname: Stephen R.
  surname: Durham
  fullname: Durham, Stephen R.
  organization: Department of Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College, London, United Kingdom
– sequence: 8
  givenname: Stephen J.
  surname: Till
  fullname: Till, Stephen J.
  organization: Allergy, Asthma and Lung Biology, King’s College London, London, United Kingdom
– sequence: 9
  givenname: David
  surname: Robinson
  fullname: Robinson, David
  organization: Virginia Mason Medical Center, Seattle, Wash
– sequence: 10
  givenname: William W.
  surname: Kwok
  fullname: Kwok, William W.
  email: bkwok@benaroyaresearch.org
  organization: Benaroya Research Institute at Virginia Mason, Seattle, Wash
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28383894$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24373351$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1rFDEUhoNU7Hb1D3ghAyIIMmu-5iMiBdn6BQUvWq9DNnPSZp1JxmSmsP--me6u1QWr5CLk5Dlvzjl5T9CR8w4Qek7wgmBSvl0v1krbBcWEpcACF_wRmhEsqrysaXGEZhgLkpcVF8foJMY1TmdWiyfomHJWMVaQGTIXPWhrrM5s143OD9cQVL_JOt-kKMRMtS2EK3B53IPLM_4mu8w1tG0WIPbexcRZlymXQW8H30PeQA-uATdknXIOwlP02Kg2wrPdPkffP328XH7Jz799_rr8cJ7rsqBDzrSpRYNZrUWBK61KVTHDDKe1YNAYtsKalSAEoRU3qqS0FLSmeMUFrBQBxubodKvbj6sOGp0qCKqVfbCdChvplZV_3jh7La_8jWSiJEVVJYHXO4Hgf44QB9nZOLWqHPgxSlKQNFCe4P9AMSclJwVP6MsDdO3H4NIkZCJ4VfNC1Il68Xvxv6re_1YCXu0AFbVqTVBO23jP1SwtMT1XbzkdfIwBjNR2UIP1U8-2lQTLyUByLScDyclAUwzfVUoPUvfqDya93yZB-tobC0FGbcFpaGwAPcjG24fTTw_SdWudTR3-gA3E-1HJSCWWF5OtJ1cThsndNkfv_i7wr9dvAXWQBnQ
CODEN JACIBY
CitedBy_id crossref_primary_10_1097_01_ASW_0000547414_38888_8d
crossref_primary_10_1038_s41551_017_0143_4
crossref_primary_10_1016_j_jaci_2015_01_029
crossref_primary_10_1111_pai_13189
crossref_primary_10_1016_j_jaci_2022_06_024
crossref_primary_10_1111_all_12661
crossref_primary_10_4168_aair_2018_10_3_189
crossref_primary_10_1586_14760584_2015_1050385
crossref_primary_10_1016_j_clim_2015_05_023
crossref_primary_10_1111_all_13436
crossref_primary_10_1111_all_15931
crossref_primary_10_1586_1744666X_2016_1147349
crossref_primary_10_1111_1541_4337_12472
crossref_primary_10_1111_all_12989
crossref_primary_10_1111_cea_12324
crossref_primary_10_1016_j_jaci_2015_02_025
crossref_primary_10_1016_j_jaci_2022_05_025
crossref_primary_10_1586_1744666X_2016_1165093
crossref_primary_10_1111_cea_14024
crossref_primary_10_1111_all_13918
crossref_primary_10_1002_eji_202249983
crossref_primary_10_1186_s40413_015_0063_2
crossref_primary_10_1097_ACI_0000000000000480
crossref_primary_10_1080_10408398_2023_2181755
crossref_primary_10_1172_JCI164501
crossref_primary_10_1016_j_jaci_2014_12_1908
crossref_primary_10_1038_pr_2017_12
crossref_primary_10_1038_s41467_024_45058_9
crossref_primary_10_1111_all_15543
crossref_primary_10_1159_000375406
crossref_primary_10_1155_2017_5746031
crossref_primary_10_1586_14760584_2014_948861
crossref_primary_10_1111_all_15749
crossref_primary_10_1111_cea_12554
crossref_primary_10_1016_j_jaci_2017_10_010
crossref_primary_10_1038_s41541_017_0014_8
crossref_primary_10_1111_cea_12552
crossref_primary_10_1513_AnnalsATS_201507_431MG
crossref_primary_10_1038_jid_2015_162
crossref_primary_10_1016_j_compbiolchem_2017_08_016
crossref_primary_10_1159_000525293
crossref_primary_10_1016_j_jaci_2015_08_046
crossref_primary_10_4168_aair_2023_15_2_125
crossref_primary_10_1007_s11882_015_0587_0
crossref_primary_10_2217_imt_2021_0133
crossref_primary_10_1016_j_jaci_2021_03_030
crossref_primary_10_1111_sji_12344
crossref_primary_10_3389_fimmu_2020_568598
crossref_primary_10_1111_all_13295
crossref_primary_10_1111_all_15276
crossref_primary_10_1016_j_iac_2015_09_001
crossref_primary_10_1016_j_jaci_2017_09_041
crossref_primary_10_1016_j_immuni_2020_07_025
crossref_primary_10_1016_j_jaci_2015_07_031
crossref_primary_10_3389_fimmu_2018_01408
crossref_primary_10_1038_nri_2016_111
crossref_primary_10_1111_all_12524
crossref_primary_10_1111_cea_12343
crossref_primary_10_2217_imt_16_1
crossref_primary_10_1016_j_ebiom_2018_09_016
crossref_primary_10_3389_fimmu_2022_916778
crossref_primary_10_1016_j_coph_2015_05_003
crossref_primary_10_1016_j_pharmthera_2022_108115
crossref_primary_10_2147_JAA_S288886
crossref_primary_10_1016_j_jaci_2022_01_016
crossref_primary_10_1007_s00005_017_0501_7
crossref_primary_10_1007_s11882_018_0801_y
crossref_primary_10_1038_s41385_018_0038_z
crossref_primary_10_1126_scitranslmed_aam9171
crossref_primary_10_1016_j_anai_2018_01_004
crossref_primary_10_1016_j_smim_2017_08_008
crossref_primary_10_1080_21645515_2017_1409315
crossref_primary_10_3389_fimmu_2015_00456
crossref_primary_10_1080_07391102_2019_1651673
crossref_primary_10_1111_all_15966
crossref_primary_10_1016_j_iac_2015_08_003
crossref_primary_10_1038_ncomms12614
crossref_primary_10_1016_j_iac_2015_08_004
crossref_primary_10_1111_all_13867
crossref_primary_10_1016_j_iac_2015_08_002
crossref_primary_10_1097_ACI_0000000000000216
crossref_primary_10_1111_cea_12653
crossref_primary_10_1016_j_coi_2020_02_005
crossref_primary_10_1016_j_mucimm_2024_03_012
crossref_primary_10_1111_pai_13042
crossref_primary_10_1007_s00105_014_3559_8
crossref_primary_10_1016_j_iac_2015_12_004
crossref_primary_10_2217_imt_14_47
crossref_primary_10_1016_j_jaci_2018_10_016
crossref_primary_10_1111_imm_12772
crossref_primary_10_1002_eji_201545869
crossref_primary_10_1016_j_jaci_2016_06_010
Cites_doi 10.1016/j.jim.2008.09.014
10.1046/j.1365-2222.1998.00432.x
10.1038/ni.1826
10.1038/nri1934
10.1016/j.jaci.2010.03.037
10.1038/ni1490
10.4049/jimmunol.151.5.2426
10.1111/j.1365-2249.2010.04148.x
10.1111/j.1398-9995.2005.00699.x
10.1084/jem.187.1.129
10.1084/jem.20030916
10.1084/jem.187.6.875
10.1016/j.jaci.2012.07.056
10.1016/j.jaci.2006.05.003
10.1016/j.jaci.2011.08.034
10.1038/ni.2035
10.1159/000236567
10.1016/j.jaci.2005.12.1358
10.1084/jem.20110236
10.4168/aair.2011.3.1.11
10.1038/ni1467
10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#
10.1172/JCI8476
10.4049/jimmunol.1000405
10.1016/j.immuni.2008.08.001
10.4049/jimmunol.172.5.2763
10.4049/jimmunol.166.11.6665
10.1084/jem.20032058
10.1159/000331868
10.1146/annurev.iy.11.040193.003501
10.1084/jem.20091885
10.1056/NEJM199908123410702
10.4049/jimmunol.180.11.7193
10.4049/jimmunol.174.6.3352
10.1084/jem.186.9.1407
ContentType Journal Article
Copyright 2013 American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
2015 INIST-CNRS
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Copyright Elsevier Limited Mar 2014
2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved. 2013
Copyright_xml – notice: 2013 American Academy of Allergy, Asthma & Immunology
– notice: American Academy of Allergy, Asthma & Immunology
– notice: 2015 INIST-CNRS
– notice: Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
– notice: Copyright Elsevier Limited Mar 2014
– notice: 2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved. 2013
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1016/j.jaci.2013.10.054
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

AIDS and Cancer Research Abstracts

MEDLINE - Academic

Entomology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 879.e7
ExternalDocumentID PMC3961577
3556035951
24373351
28383894
10_1016_j_jaci_2013_10_054
S0091674913017491
1_s2_0_S0091674913017491
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institute of Allergy and Infectious Diseases (NIAID)
– fundername: National Institutes of Health (NIH)
– fundername: European Academy of Allergy and Clinical Immunology (EAACI)–World Allergy Organization (WAO)
– fundername: NIH
  grantid: AI095074
– fundername: ALK-Abelló, Novartis, Stallergenes (Spain), and Letti (Spain)
– fundername: NIAID NIH HHS
  grantid: AI095074
– fundername: NIAID NIH HHS
  grantid: HHSN272200700046C
– fundername: NIAID NIH HHS
  grantid: R01 AI095074
– fundername: Medical Research Council
  grantid: G1000758
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c652t-3cf89d038c9507ca6a73f3f42893edf3b0c36e991274fa622692820b49eba1e33
IEDL.DBID .~1
ISSN 0091-6749
1097-6825
IngestDate Thu Aug 21 14:08:52 EDT 2025
Thu Jul 10 18:32:21 EDT 2025
Fri Jul 11 06:29:36 EDT 2025
Wed Aug 13 07:30:07 EDT 2025
Mon Jul 21 05:53:03 EDT 2025
Wed Apr 02 07:17:46 EDT 2025
Tue Jul 01 04:32:24 EDT 2025
Thu Apr 24 23:08:15 EDT 2025
Sun Apr 06 06:53:40 EDT 2025
Wed Apr 02 07:27:48 EDT 2025
Tue Aug 26 19:48:29 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords ASIT
pollen
pMHCII
allergy
peripheral tolerance
T cells
CD4
PE
Immunotherapy
peptide–MHC class II tetramer
ex vivo
epitope
TGP
Allergen-specific immunotherapy
Timothy grass pollen
Peptide–MHC class II
Phycoerythrin
Allergy
Immunopathology
CD4 T lymphocyte
Immune response
Antigenic determinant
Peptides
Major histocompatibility system
Class II histocompatibility antigen
Tolerance
Immunology
Treatment
peptide-MHC class II tetramer
Ex vivo
Tetramer
T-Lymphocyte
Pollen
Allergen
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c652t-3cf89d038c9507ca6a73f3f42893edf3b0c36e991274fa622692820b49eba1e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3961577
PMID 24373351
PQID 1644784598
PQPubID 105664
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3961577
proquest_miscellaneous_1516744615
proquest_miscellaneous_1504164154
proquest_journals_1644784598
pubmed_primary_24373351
pascalfrancis_primary_28383894
crossref_citationtrail_10_1016_j_jaci_2013_10_054
crossref_primary_10_1016_j_jaci_2013_10_054
elsevier_sciencedirect_doi_10_1016_j_jaci_2013_10_054
elsevier_clinicalkeyesjournals_1_s2_0_S0091674913017491
elsevier_clinicalkey_doi_10_1016_j_jaci_2013_10_054
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2014
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Lissina, Ladell, Skowera, Clement, Edwards, Seggewiss (bib11) 2009; 340
Sallusto, Lenig, Mackay, Lanzavecchia (bib16) 1998; 187
Pepper, Linehan, Pagan, Zell, Dileepan, Cleary (bib19) 2010; 11
Margot, Ford, Evavold (bib30) 2005; 174
Oseroff, Peters, Pasquetto, Moutaftsi, Sidney, Panchanathan (bib28) 2008; 180
Steinman (bib29) 2008; 29
Wilson, Lima, Durham (bib2) 2005; 60
Fujita, Meyer, Akdis, Akdis (bib3) 2012; 96
Maggi (bib4) 2010; 161
Wherry (bib18) 2011; 12
Hintzen, de Jong, Lens, Brouwer, Baars, van Lier (bib32) 1993; 151
Zhao, Zhao, Fett, Trandem, Fleming, Perlman (bib25) 2011; 208
Bonecchi, Bianchi, Bordignon, D'Ambrosio, Lang, Borsatti (bib14) 1998; 187
Larche, Akdis, Valenta (bib6) 2006; 6
Kwok, Roti, Delong, Tan, Wambre, James (bib12) 2010; 125
Dahl, Kapp, Colombo, de Monchy, Rak, Emminger (bib8) 2006; 118
Vrtala, Grote, Duchene, Van, Kraft, Scheiner (bib7) 1993; 102
Durham, Walker, Varga, Jacobson, O'Brien, Noble (bib1) 1999; 341
Muller, Karamfilov, Kahlert, Stuwe, Fahlbusch, Cromwell (bib21) 1998; 28
Oseroff, Sidney, Kotturi, Kolla, Alam, Broide (bib22) 2010; 185
Skokos, Shakhar, Varma, Waite, Cameron, Lindquist (bib31) 2007; 8
Shafiani, Tucker-Heard, Kariyone, Takatsu, Urdahl (bib24) 2010; 207
Sercarz, Lehmann, Ametani, Benichou, Miller, Moudgil (bib27) 1993; 11
Reefer, Carneiro, Custis, Platts-Mills, Sung, Hammer (bib23) 2004; 172
Akkoc, Akdis, Akdis (bib5) 2011; 3
Hendriks, Xiao, Borst (bib20) 2003; 198
Mobs, Ipsen, Mayer, Slotosch, Petersen, Wurtzen (bib34) 2012; 130
Wambre, Delong, James, LaFond, Robinson, Kwok (bib17) 2012; 129
Hamann, Baars, Rep, Hooibrink, Kerkhof-Garde, Klein (bib33) 1997; 186
Acosta-Rodriguez, Rivino, Geginat, Jarrossay, Gattorno, Lanzavecchia (bib13) 2007; 8
Akdis, Verhagen, Taylor, Karamloo, Karagiannidis, Crameri (bib26) 2004; 199
Cosmi, Annunziato, Galli, Maggi, Nagata, Romagnani (bib15) 2000; 30
Novak, Liu, Nepom, Kwok (bib10) 1999; 104
Durham, Yang, Pedersen, Johansen, Rak (bib9) 2006; 117
Durham (10.1016/j.jaci.2013.10.054_bib1) 1999; 341
Pepper (10.1016/j.jaci.2013.10.054_bib19) 2010; 11
Wambre (10.1016/j.jaci.2013.10.054_bib17) 2012; 129
Lissina (10.1016/j.jaci.2013.10.054_bib11) 2009; 340
Shafiani (10.1016/j.jaci.2013.10.054_bib24) 2010; 207
Maggi (10.1016/j.jaci.2013.10.054_bib4) 2010; 161
Akdis (10.1016/j.jaci.2013.10.054_bib26) 2004; 199
Larche (10.1016/j.jaci.2013.10.054_bib6) 2006; 6
Wherry (10.1016/j.jaci.2013.10.054_bib18) 2011; 12
Novak (10.1016/j.jaci.2013.10.054_bibE1) 2001; 166
Vrtala (10.1016/j.jaci.2013.10.054_bib7) 1993; 102
Sallusto (10.1016/j.jaci.2013.10.054_bib16) 1998; 187
Mobs (10.1016/j.jaci.2013.10.054_bib34) 2012; 130
Zhao (10.1016/j.jaci.2013.10.054_bib25) 2011; 208
Dahl (10.1016/j.jaci.2013.10.054_bib8) 2006; 118
Fujita (10.1016/j.jaci.2013.10.054_bib3) 2012; 96
Hamann (10.1016/j.jaci.2013.10.054_bib33) 1997; 186
Oseroff (10.1016/j.jaci.2013.10.054_bib22) 2010; 185
Acosta-Rodriguez (10.1016/j.jaci.2013.10.054_bib13) 2007; 8
Steinman (10.1016/j.jaci.2013.10.054_bib29) 2008; 29
Novak (10.1016/j.jaci.2013.10.054_bib10) 1999; 104
Oseroff (10.1016/j.jaci.2013.10.054_bib28) 2008; 180
Akkoc (10.1016/j.jaci.2013.10.054_bib5) 2011; 3
Hintzen (10.1016/j.jaci.2013.10.054_bib32) 1993; 151
Skokos (10.1016/j.jaci.2013.10.054_bib31) 2007; 8
Margot (10.1016/j.jaci.2013.10.054_bib30) 2005; 174
Wilson (10.1016/j.jaci.2013.10.054_bib2) 2005; 60
Durham (10.1016/j.jaci.2013.10.054_bib9) 2006; 117
Cosmi (10.1016/j.jaci.2013.10.054_bib15) 2000; 30
Muller (10.1016/j.jaci.2013.10.054_bib21) 1998; 28
Sercarz (10.1016/j.jaci.2013.10.054_bib27) 1993; 11
Bonecchi (10.1016/j.jaci.2013.10.054_bib14) 1998; 187
Reefer (10.1016/j.jaci.2013.10.054_bib23) 2004; 172
Hendriks (10.1016/j.jaci.2013.10.054_bib20) 2003; 198
Kwok (10.1016/j.jaci.2013.10.054_bib12) 2010; 125
References_xml – volume: 6
  start-page: 761
  year: 2006
  end-page: 771
  ident: bib6
  article-title: Immunological mechanisms of allergen-specific immunotherapy
  publication-title: Nat Rev Immunol
– volume: 118
  start-page: 434
  year: 2006
  end-page: 440
  ident: bib8
  article-title: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
  publication-title: J Allergy Clin Immunol
– volume: 96
  start-page: 30
  year: 2012
  end-page: 38
  ident: bib3
  article-title: Mechanisms of immune tolerance to allergens
  publication-title: Chem Immunol Allergy
– volume: 8
  start-page: 639
  year: 2007
  end-page: 646
  ident: bib13
  article-title: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
  publication-title: Nat Immunol
– volume: 3
  start-page: 11
  year: 2011
  end-page: 20
  ident: bib5
  article-title: Update in the mechanisms of allergen-specific immunotherapy
  publication-title: Allergy Asthma Immunol Res
– volume: 8
  start-page: 835
  year: 2007
  end-page: 844
  ident: bib31
  article-title: Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes
  publication-title: Nat Immunol
– volume: 117
  start-page: 802
  year: 2006
  end-page: 809
  ident: bib9
  article-title: Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis
  publication-title: J Allergy Clin Immunol
– volume: 12
  start-page: 492
  year: 2011
  end-page: 499
  ident: bib18
  article-title: T cell exhaustion
  publication-title: Nat Immunol
– volume: 208
  start-page: 1571
  year: 2011
  end-page: 1577
  ident: bib25
  article-title: IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis
  publication-title: J Exp Med
– volume: 129
  start-page: 544
  year: 2012
  end-page: 551
  ident: bib17
  article-title: Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy
  publication-title: J Allergy Clin Immunol
– volume: 207
  start-page: 1409
  year: 2010
  end-page: 1420
  ident: bib24
  article-title: Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis
  publication-title: J Exp Med
– volume: 185
  start-page: 943
  year: 2010
  end-page: 955
  ident: bib22
  article-title: Molecular determinants of T cell epitope recognition to the common Timothy grass allergen
  publication-title: J Immunol
– volume: 180
  start-page: 7193
  year: 2008
  end-page: 7202
  ident: bib28
  article-title: Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve
  publication-title: J Immunol
– volume: 187
  start-page: 129
  year: 1998
  end-page: 134
  ident: bib14
  article-title: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
  publication-title: J Exp Med
– volume: 187
  start-page: 875
  year: 1998
  end-page: 883
  ident: bib16
  article-title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
  publication-title: J Exp Med
– volume: 130
  start-page: 1108
  year: 2012
  end-page: 1116.e6
  ident: bib34
  article-title: Birch pollen immunotherapy results in long-term loss of Bet v 1-specific T(H)2 responses, transient T(R)1 activation, and synthesis of IgE-blocking antibodies
  publication-title: J Allergy Clin Immunol
– volume: 60
  start-page: 4
  year: 2005
  end-page: 12
  ident: bib2
  article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis
  publication-title: Allergy
– volume: 340
  start-page: 11
  year: 2009
  end-page: 24
  ident: bib11
  article-title: Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers
  publication-title: J Immunol Methods
– volume: 172
  start-page: 2763
  year: 2004
  end-page: 2772
  ident: bib23
  article-title: A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen
  publication-title: J Immunol
– volume: 125
  start-page: 1407
  year: 2010
  end-page: 1409
  ident: bib12
  article-title: Direct ex vivo analysis of allergen-specific CD4+ T cells
  publication-title: J Allergy Clin Immunol
– volume: 198
  start-page: 1369
  year: 2003
  end-page: 1380
  ident: bib20
  article-title: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool
  publication-title: J Exp Med
– volume: 102
  start-page: 160
  year: 1993
  end-page: 169
  ident: bib7
  article-title: Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity
  publication-title: Int Arch Allergy Immunol
– volume: 11
  start-page: 83
  year: 2010
  end-page: 89
  ident: bib19
  article-title: Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells
  publication-title: Nat Immunol
– volume: 11
  start-page: 729
  year: 1993
  end-page: 766
  ident: bib27
  article-title: Dominance and crypticity of T cell antigenic determinants
  publication-title: Annu Rev Immunol
– volume: 199
  start-page: 1567
  year: 2004
  end-page: 1575
  ident: bib26
  article-title: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
  publication-title: J Exp Med
– volume: 341
  start-page: 468
  year: 1999
  end-page: 475
  ident: bib1
  article-title: Long-term clinical efficacy of grass-pollen immunotherapy
  publication-title: N Engl J Med
– volume: 161
  start-page: 10
  year: 2010
  end-page: 18
  ident: bib4
  article-title: T-cell responses induced by allergen-specific immunotherapy
  publication-title: Clin Exp Immunol
– volume: 29
  start-page: 319
  year: 2008
  end-page: 324
  ident: bib29
  article-title: Dendritic cells in vivo: a key target for a new vaccine science
  publication-title: Immunity
– volume: 186
  start-page: 1407
  year: 1997
  end-page: 1418
  ident: bib33
  article-title: Phenotypic and functional separation of memory and effector human CD8+ T cells
  publication-title: J Exp Med
– volume: 104
  start-page: R63
  year: 1999
  end-page: R67
  ident: bib10
  article-title: MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen
  publication-title: J Clin Invest
– volume: 151
  start-page: 2426
  year: 1993
  end-page: 2435
  ident: bib32
  article-title: Regulation of CD27 expression on subsets of mature T-lymphocytes
  publication-title: J Immunol
– volume: 28
  start-page: 1538
  year: 1998
  end-page: 1548
  ident: bib21
  article-title: Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens
  publication-title: Clin Exp Allergy
– volume: 30
  start-page: 2972
  year: 2000
  end-page: 2979
  ident: bib15
  article-title: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease
  publication-title: Eur J Immunol
– volume: 174
  start-page: 3352
  year: 2005
  end-page: 3358
  ident: bib30
  article-title: Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151
  publication-title: J Immunol
– volume: 340
  start-page: 11
  year: 2009
  ident: 10.1016/j.jaci.2013.10.054_bib11
  article-title: Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2008.09.014
– volume: 28
  start-page: 1538
  year: 1998
  ident: 10.1016/j.jaci.2013.10.054_bib21
  article-title: Mapping of T-cell epitopes of Phl p 5: evidence for crossreacting and non-crossreacting T-cell epitopes within Phl p 5 isoallergens
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.1998.00432.x
– volume: 11
  start-page: 83
  year: 2010
  ident: 10.1016/j.jaci.2013.10.054_bib19
  article-title: Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells
  publication-title: Nat Immunol
  doi: 10.1038/ni.1826
– volume: 6
  start-page: 761
  year: 2006
  ident: 10.1016/j.jaci.2013.10.054_bib6
  article-title: Immunological mechanisms of allergen-specific immunotherapy
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1934
– volume: 125
  start-page: 1407
  year: 2010
  ident: 10.1016/j.jaci.2013.10.054_bib12
  article-title: Direct ex vivo analysis of allergen-specific CD4+ T cells
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.03.037
– volume: 8
  start-page: 835
  year: 2007
  ident: 10.1016/j.jaci.2013.10.054_bib31
  article-title: Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes
  publication-title: Nat Immunol
  doi: 10.1038/ni1490
– volume: 151
  start-page: 2426
  year: 1993
  ident: 10.1016/j.jaci.2013.10.054_bib32
  article-title: Regulation of CD27 expression on subsets of mature T-lymphocytes
  publication-title: J Immunol
  doi: 10.4049/jimmunol.151.5.2426
– volume: 161
  start-page: 10
  year: 2010
  ident: 10.1016/j.jaci.2013.10.054_bib4
  article-title: T-cell responses induced by allergen-specific immunotherapy
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2010.04148.x
– volume: 60
  start-page: 4
  year: 2005
  ident: 10.1016/j.jaci.2013.10.054_bib2
  article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2005.00699.x
– volume: 187
  start-page: 129
  year: 1998
  ident: 10.1016/j.jaci.2013.10.054_bib14
  article-title: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
  publication-title: J Exp Med
  doi: 10.1084/jem.187.1.129
– volume: 198
  start-page: 1369
  year: 2003
  ident: 10.1016/j.jaci.2013.10.054_bib20
  article-title: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool
  publication-title: J Exp Med
  doi: 10.1084/jem.20030916
– volume: 187
  start-page: 875
  year: 1998
  ident: 10.1016/j.jaci.2013.10.054_bib16
  article-title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
  publication-title: J Exp Med
  doi: 10.1084/jem.187.6.875
– volume: 130
  start-page: 1108
  year: 2012
  ident: 10.1016/j.jaci.2013.10.054_bib34
  article-title: Birch pollen immunotherapy results in long-term loss of Bet v 1-specific T(H)2 responses, transient T(R)1 activation, and synthesis of IgE-blocking antibodies
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.07.056
– volume: 118
  start-page: 434
  year: 2006
  ident: 10.1016/j.jaci.2013.10.054_bib8
  article-title: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.05.003
– volume: 129
  start-page: 544
  year: 2012
  ident: 10.1016/j.jaci.2013.10.054_bib17
  article-title: Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.08.034
– volume: 12
  start-page: 492
  year: 2011
  ident: 10.1016/j.jaci.2013.10.054_bib18
  article-title: T cell exhaustion
  publication-title: Nat Immunol
  doi: 10.1038/ni.2035
– volume: 102
  start-page: 160
  year: 1993
  ident: 10.1016/j.jaci.2013.10.054_bib7
  article-title: Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000236567
– volume: 117
  start-page: 802
  year: 2006
  ident: 10.1016/j.jaci.2013.10.054_bib9
  article-title: Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.12.1358
– volume: 208
  start-page: 1571
  year: 2011
  ident: 10.1016/j.jaci.2013.10.054_bib25
  article-title: IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis
  publication-title: J Exp Med
  doi: 10.1084/jem.20110236
– volume: 3
  start-page: 11
  year: 2011
  ident: 10.1016/j.jaci.2013.10.054_bib5
  article-title: Update in the mechanisms of allergen-specific immunotherapy
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2011.3.1.11
– volume: 8
  start-page: 639
  year: 2007
  ident: 10.1016/j.jaci.2013.10.054_bib13
  article-title: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
  publication-title: Nat Immunol
  doi: 10.1038/ni1467
– volume: 30
  start-page: 2972
  year: 2000
  ident: 10.1016/j.jaci.2013.10.054_bib15
  article-title: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#
– volume: 104
  start-page: R63
  year: 1999
  ident: 10.1016/j.jaci.2013.10.054_bib10
  article-title: MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen
  publication-title: J Clin Invest
  doi: 10.1172/JCI8476
– volume: 185
  start-page: 943
  year: 2010
  ident: 10.1016/j.jaci.2013.10.054_bib22
  article-title: Molecular determinants of T cell epitope recognition to the common Timothy grass allergen
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1000405
– volume: 29
  start-page: 319
  year: 2008
  ident: 10.1016/j.jaci.2013.10.054_bib29
  article-title: Dendritic cells in vivo: a key target for a new vaccine science
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.08.001
– volume: 172
  start-page: 2763
  year: 2004
  ident: 10.1016/j.jaci.2013.10.054_bib23
  article-title: A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.5.2763
– volume: 166
  start-page: 6665
  year: 2001
  ident: 10.1016/j.jaci.2013.10.054_bibE1
  article-title: Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.11.6665
– volume: 199
  start-page: 1567
  year: 2004
  ident: 10.1016/j.jaci.2013.10.054_bib26
  article-title: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20032058
– volume: 96
  start-page: 30
  year: 2012
  ident: 10.1016/j.jaci.2013.10.054_bib3
  article-title: Mechanisms of immune tolerance to allergens
  publication-title: Chem Immunol Allergy
  doi: 10.1159/000331868
– volume: 11
  start-page: 729
  year: 1993
  ident: 10.1016/j.jaci.2013.10.054_bib27
  article-title: Dominance and crypticity of T cell antigenic determinants
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.11.040193.003501
– volume: 207
  start-page: 1409
  year: 2010
  ident: 10.1016/j.jaci.2013.10.054_bib24
  article-title: Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis
  publication-title: J Exp Med
  doi: 10.1084/jem.20091885
– volume: 341
  start-page: 468
  year: 1999
  ident: 10.1016/j.jaci.2013.10.054_bib1
  article-title: Long-term clinical efficacy of grass-pollen immunotherapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199908123410702
– volume: 180
  start-page: 7193
  year: 2008
  ident: 10.1016/j.jaci.2013.10.054_bib28
  article-title: Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.11.7193
– volume: 174
  start-page: 3352
  year: 2005
  ident: 10.1016/j.jaci.2013.10.054_bib30
  article-title: Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.6.3352
– volume: 186
  start-page: 1407
  year: 1997
  ident: 10.1016/j.jaci.2013.10.054_bib33
  article-title: Phenotypic and functional separation of memory and effector human CD8+ T cells
  publication-title: J Exp Med
  doi: 10.1084/jem.186.9.1407
SSID ssj0009389
Score 2.453651
Snippet Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the design of...
Background Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the...
Background: Understanding the mechanisms by which the immune system induces and controls allergic inflammation at the T-cell epitope level is critical for the...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 872
SubjectTerms Allergens - immunology
Allergies
allergy
Allergy and Immunology
Biological and medical sciences
CD4
CD4-Positive T-Lymphocytes - immunology
Cytokines
Desensitization, Immunologic
epitope
Epitopes, T-Lymphocyte - immunology
ex vivo
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Grasses
Humans
Immune Tolerance
Immunopathology
Immunophenotyping
Immunotherapy
Lymphocytes
Medical sciences
Peptides
peptide–MHC class II tetramer
peripheral tolerance
Phleum - immunology
pollen
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Statistical analysis
T cell receptors
T cells
Th1 Cells - immunology
Th2 Cells - immunology
Tumor Necrosis Factor Receptor Superfamily, Member 7 - analysis
Title Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674913017491
https://www.clinicalkey.es/playcontent/1-s2.0-S0091674913017491
https://dx.doi.org/10.1016/j.jaci.2013.10.054
https://www.ncbi.nlm.nih.gov/pubmed/24373351
https://www.proquest.com/docview/1644784598
https://www.proquest.com/docview/1504164154
https://www.proquest.com/docview/1516744615
https://pubmed.ncbi.nlm.nih.gov/PMC3961577
Volume 133
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBalgzEYZb_ntgsa7K2otS3Zsh5LtpJttE8t9E3IssRcVsfU6UNf-rf3LpadZesyGHkIkU-JpTudPjnf3RHyKTWKY-Q3Mz6tmJBwQFGSG5ZKQB-lq0zi8NHA6Vk-uxDfLrPLLTIdYmGQVhl8f-_Tl946tByF2Txq6xpjfBVS6BV44QTfMIJdSLTyw_sVzUPxoofAKmEoHQJneo7XlbE10rv4ITK8MvG3zel5azqYMt_XungMjP7Oqfxlkzp5QXYCuqTH_QBeki3XvCJPT8P_56-JX5ab97WlNcaFhOirO3o9r6DVdRQrq2A4JusGwelncUDPGT7gpzc9oRbk6oaahroW_EHr2FBJd0GvDZbyekMuTr6cT2csVFpgNs_SBePWF6qKeWEV4ENrciO55x6OJoq7yvMytjx3ACXhDOtNDpBNwVEtLoVyJWqTvyXbzbxx7wm1Pi0q57gpVC4KI8o8Kw2W80hV7Lg1EUmGKdY2pCHHahg_9cA3u9KoFo1qwTZQS0QOxj5tn4RjozQfNKeH8FJwiBr2iI295GO9XBfWdKcT3aU61n_YXUSyseea6f7zFydrZjUODRAfvBQI7A92pld3AQBWFiJTRUQ-jpfBJ6AdmMbNb0Emg-WXwwoUm2RwEAIAbUTe9aa7ugHMd8UzGJlcM-pRAHOSr19p6h_L3ORcwTdKufufc7JHnsEn0ZP89sn24ubWfQDUtygny2U9IU-Ov36fnT0AHKVWTQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJ8EkhPheYAwj8TaZJbHz4cepMHVs7VMn7c1yHFtkYmm0dA_899w1TkphFAn1IZJ918S-8_nn5D4I-RhryTHym2kXl0xkcECRGdcszgB9FLbUkcVXA9NZOrkUX6-Sqx0y7mNh0K3S2_7Opq-stW859rN53FQVxvhKdKGXYIUjvDwgu5idKhmR3ZOz88lsnXuX5x0KlhFDBh8707l5XWtToYcX_4ROXon42_70uNEtzJrryl3ch0d_d6v8ZZ86fUqeeIBJT7oxPCM7tn5OHk79J_QXxK0qzrvK0ApDQ3wA1g96syih1bYUi6tgRCZre8LxZ3FE5wzf8dPbzqcW6Kqa6praBkxCY1lfTHdJbzRW83pJLk-_zMcT5ostMJMm8ZJx43JZhjw3EiCi0anOuOMOTieS29LxIjQ8tYAm4RjrdAqoTcJpLSyEtAUKlL8io3pR231CjYvz0lquc5mKXIsiTQqNFT1iGVpudECifoqV8ZnIsSDGd9W7nF0rFItCsWAbiCUgRwNP0-Xh2ErNe8mpPsIUbKKCbWIrV3Yfl239sm5VpNpYheoP1QtIMnBuaO8_73i4oVbD0AD0wU8CwUGvZ2r9FIBhs1wkMg_Ih6EbzALqga7t4g5oEliBKSxCsY0GByEA0wbkdae66wfAlFc8gZFlG0o9EGBa8s2euvq2Sk_OJfxjlr35zzl5Tx5N5tMLdXE2O39L9qBHdD5_B2S0vL2z7wAELotDv8h_AqobWP4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Specific+immunotherapy+modifies+allergen-specific+CD4%2B+T-cell+responses+in+an+epitope-dependent+manner&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Wambre%2C+Erik&rft.au=DeLong%2C+Jonathan+H.&rft.au=James%2C+Eddie+A.&rft.au=Torres-Chinn%2C+Nadia&rft.date=2014-03-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=133&rft.issue=3&rft.spage=872&rft.epage=879.e7&rft_id=info:doi/10.1016%2Fj.jaci.2013.10.054&rft.externalDocID=S0091674913017491
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674913X0017X%2Fcov150h.gif